{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T18:14:48Z","timestamp":1791915288624,"version":"4.3.4"},"reference-count":34,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DDDT"],"DOI":"10.2147\/dddt.s591017","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T12:30:13Z","timestamp":1776083413000},"page":"1-25","source":"Crossref","is-referenced-by-count":2,"title":["Preclinical Pharmacokinetics, ADME, and Drug-Drug Interaction Evaluation of S024, a Novel p38\/MK2 Inhibitor for Rheumatoid Arthritis"],"prefix":"10.2147","volume":"Volume 20","author":[{"given":"Qianlei","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jigang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjun","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,4]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s13075-022-02851-5","volume":"24","author":"Duong","year":"2022","journal-title":"Arthritis Res Ther"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"e594","DOI":"10.1016\/S2665-9913(23)00211-4","volume":"5","author":"Black","year":"2023","journal-title":"Lancet Rheumatol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1093\/rheumatology\/kew318","volume":"56","author":"Alp\u00edzar-Rodr\u00edguez","year":"2017","journal-title":"Rheumatology"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1016\/S0140-6736(17)31491-5","volume":"389","author":"Burmester","year":"2017","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1016\/S0140-6736(17)31472-1","volume":"389","author":"McInnes","year":"2017","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.0105-2896.2009.00859.x","volume":"233","author":"Bartok","year":"2010","journal-title":"Immunol Rev"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41392-023-01331-9","volume":"8","author":"Ding","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nature01661","volume":"423","author":"Firestein","year":"2003","journal-title":"Nature"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/labinvest.2012.177","volume":"93","author":"Li","year":"2013","journal-title":"Lab Invest"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.pharep.2017.03.023","volume":"69","author":"Singh","year":"2017","journal-title":"Pharmacol Rep"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"eaal1601","DOI":"10.1126\/scisignal.aal1601","volume":"11","author":"Jones","year":"2018","journal-title":"Sci Signal"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"5729","DOI":"10.1002\/slct.202100406","volume":"6","author":"Machado","year":"2021","journal-title":"Chem Select"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.tibs.2017.12.002","volume":"43","author":"Menon","year":"2018","journal-title":"Trends Biochem Sci"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.trsl.2022.06.005","volume":"249","author":"Malona","year":"2022","journal-title":"Transl Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.122.541040","volume":"385","author":"Hope","year":"2023","journal-title":"J Pharmacol Exp Ther"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"106861","DOI":"10.1016\/j.phrs.2023.106861","volume":"194","author":"Tran","year":"2023","journal-title":"Pharmacol Res"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1021\/acsmedchemlett.4c00393","volume":"15","author":"Abdel-Magid","year":"2024","journal-title":"ACS Med Chem Lett"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1080\/13543776.2020.1749263","volume":"30","author":"Haller","year":"2020","journal-title":"Expert Opin Ther Pat"},{"key":"ref19","unstructured":"A Phase 2 multicenter, randomized, double-blinded, placebo-controlled, parallel-group study to evaluate the efficacy and safety of a mitogen-activated protein kinase-activated protein kinase 2 (MK2) inhibitor in active ankylosing spondylitis. ACR Meeting Abstracts. Available from: https:\/\/acrabstracts.org\/abstract\/a-phase-2-multicenter-randomized-double-blinded-placebo-controlled-parallel-group-study-to-evaluate-the-efficacy-and-safety-of-a-mitogen-activated-protein-kinase-activated-protein-kinase-2-mk2-i\/. Accessed January 14, 2026."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/acr2.11517","volume":"5","author":"Gordon","year":"2023","journal-title":"ACR Open Rheumatol"},{"key":"ref21","unstructured":"Inc AT. Aclaris therapeutics announces top-line results from 12-week Phase 2b trial of oral zunsemetinib (ATI-450) for moderate to severe rheumatoid arthritis and provides corporate update. GlobeNewswire News Room. 2023. Available from: https:\/\/www.globenewswire.com\/news-release\/2023\/11\/13\/2778890\/37216\/en\/Aclaris-Therapeutics-Announces-Top-line-Results-from-12-Week-Phase-2b-Trial-of-Oral-Zunsemetinib-ATI-450-for-Moderate-to-Severe-Rheumatoid-Arthritis-and-Provides-Corporate-Update.html. Accessed January 14, 2026."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1084\/jem.20172063","volume":"215","author":"Wang","year":"2018","journal-title":"J Exp Med"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"116614","DOI":"10.1016\/j.bmc.2022.116614","volume":"56","author":"Das","year":"2022","journal-title":"Bioorg Med Chem"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"8038","DOI":"10.3390\/molecules28248038","volume":"28","author":"Stielow","year":"2023","journal-title":"Molecules"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1021\/acs.jmedchem.4c01925","volume":"68","author":"Fu","year":"2025","journal-title":"J Med Chem"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.jpba.2015.07.024","volume":"115","author":"Xu","year":"2015","journal-title":"J Pharm Biomed Anal"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"403","DOI":"10.2174\/1389200221666200620210522","volume":"21","author":"Sudsakorn","year":"2020","journal-title":"Curr Drug Metab"},{"key":"ref28","unstructured":"Committee for Human Medicinal Products (CHMP), European Medicines Agency. Guideline on the investigation of drug interactions. European Medicines Agency; 2012. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-investigation-drug-interactions-revision-1_en.pdf. Accessed March 26, 2026."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"3442","DOI":"10.1016\/j.xphs.2017.09.005","volume":"106","author":"Di","year":"2017","journal-title":"J Pharm Sci"},{"key":"ref30","unstructured":"Center for Drug Evaluation and Research, US Food and Drug Administration. In vitro drug interaction studies: cytochrome P-450 enzyme- and transporter-mediated drug interactions. US Department of Health and Human Services; 2020."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1080\/17460441.2021.1961741","volume":"16","author":"Di","year":"2021","journal-title":"Expert Opin on Drug Discov"},{"key":"ref32","unstructured":"Decoding the key role of plasma protein binding in drug-drug interactions - WuXi AppTec DMPK. Available from: https:\/\/dmpkservice.wuxiapptec.com\/articles\/451-decoding-the-key-role-of-plasma-protein-binding-in-drug-drug-interactions\/. Accessed March 9, 2026."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"114413","DOI":"10.1016\/j.ejmech.2022.114413","volume":"237","author":"Wang","year":"2022","journal-title":"Eur J Med Chem"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.3390\/ijms23042002","volume":"23","author":"Garrido-Godino","year":"2022","journal-title":"Int J Mol Sci"}],"container-title":["Drug Design, Development and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/article\/download\/114005","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/article\/download\/114005","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T12:30:17Z","timestamp":1776083417000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/preclinical-pharmacokinetics-adme-and-drug-drug-interaction-evaluation-peer-reviewed-fulltext-article-DDDT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":34,"URL":"https:\/\/doi.org\/10.2147\/dddt.s591017","relation":{},"ISSN":["1177-8881"],"issn-type":[{"value":"1177-8881","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]}}}